Vectored immunoprophylaxis and treatment of SARS-CoV-2 infection in a preclinical model.

Proc Natl Acad Sci U S A · 2023 · PMC10266030 · PMID 37252952

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

This difference did not reach statistical significance but was confirmed in a dose–response analysis, which showed that the AAV2.retro vector was about 10-fold more effective.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.